DK1631373T3 - Mikropellets, fremgangsmåde til fremstilling af disse samt deres anvendelse - Google Patents

Mikropellets, fremgangsmåde til fremstilling af disse samt deres anvendelse

Info

Publication number
DK1631373T3
DK1631373T3 DK04735882T DK04735882T DK1631373T3 DK 1631373 T3 DK1631373 T3 DK 1631373T3 DK 04735882 T DK04735882 T DK 04735882T DK 04735882 T DK04735882 T DK 04735882T DK 1631373 T3 DK1631373 T3 DK 1631373T3
Authority
DK
Denmark
Prior art keywords
micropellets
formulations
preparation
active material
fluidized bed
Prior art date
Application number
DK04735882T
Other languages
Danish (da)
English (en)
Inventor
Norbert Poellinger
Manfred Struschka
Franz X Schwarz
Armin Prasch
Bernhard Luy
Original Assignee
Glatt Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Glatt Gmbh filed Critical Glatt Gmbh
Application granted granted Critical
Publication of DK1631373T3 publication Critical patent/DK1631373T3/da

Links

Classifications

    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
    • B01J2/00—Processes or devices for granulating materials, e.g. fertilisers in general; Rendering particulate materials free flowing in general, e.g. making them hydrophobic
    • B01J2/16—Processes or devices for granulating materials, e.g. fertilisers in general; Rendering particulate materials free flowing in general, e.g. making them hydrophobic by suspending the powder material in a gas, e.g. in fluidised beds or as a falling curtain
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
    • A61K31/7048—Compounds having saccharide radicals and heterocyclic rings having oxygen as a ring hetero atom, e.g. leucoglucosan, hesperidin, erythromycin, nystatin, digitoxin or digoxin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1629—Organic macromolecular compounds
    • A61K9/1641—Organic macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyethylene glycol, poloxamers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5073—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals having two or more different coatings optionally including drug-containing subcoatings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Communicable Diseases (AREA)
  • Molecular Biology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Oncology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Glanulating (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
DK04735882T 2003-06-07 2004-06-03 Mikropellets, fremgangsmåde til fremstilling af disse samt deres anvendelse DK1631373T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE10325989A DE10325989A1 (de) 2003-06-07 2003-06-07 Verfahren zur Herstellung von und daraus resultierende Mikropellets sowie deren Verwendung
PCT/EP2004/005993 WO2004108266A1 (fr) 2003-06-07 2004-06-03 Micropellets, leurs procedes de production et leur utilisation

Publications (1)

Publication Number Publication Date
DK1631373T3 true DK1631373T3 (da) 2009-04-14

Family

ID=33494906

Family Applications (1)

Application Number Title Priority Date Filing Date
DK04735882T DK1631373T3 (da) 2003-06-07 2004-06-03 Mikropellets, fremgangsmåde til fremstilling af disse samt deres anvendelse

Country Status (9)

Country Link
US (1) US20060115539A1 (fr)
EP (1) EP1631373B1 (fr)
JP (1) JP2006527223A (fr)
AT (1) ATE418383T1 (fr)
DE (2) DE10325989A1 (fr)
DK (1) DK1631373T3 (fr)
ES (1) ES2318295T3 (fr)
PT (1) PT1631373E (fr)
WO (1) WO2004108266A1 (fr)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE10026698A1 (de) 2000-05-30 2001-12-06 Basf Ag Selbstemulgierende Wirkstoffformulierung und Verwendung dieser Formulierung
US8377952B2 (en) 2003-08-28 2013-02-19 Abbott Laboratories Solid pharmaceutical dosage formulation
US8025899B2 (en) 2003-08-28 2011-09-27 Abbott Laboratories Solid pharmaceutical dosage form
MXPA06005913A (es) * 2003-12-04 2006-06-27 Pfizer Prod Inc Formas de dosificacion de multiparticulas de azitromicina por procedimientos basados en liquidos.
JP5138362B2 (ja) 2004-03-23 2013-02-06 ノバルティス アーゲー 医薬組成物
DE102005047561A1 (de) * 2005-10-04 2007-04-05 Bayer Healthcare Ag Feste, oral applizierbare pharmazeutische Darreichungsformen mit schneller Wirkstofffreisetzung
DE102006001554A1 (de) * 2006-01-05 2007-07-12 Ipc Process-Center Gmbh & Co. Micropellets für die Herstellung von Tiernahrungspellets
JP5141115B2 (ja) * 2006-07-11 2013-02-13 大正製薬株式会社 不快味を呈する薬物含有製剤粒子
CA2669938C (fr) * 2006-11-15 2016-01-05 Abbott Laboratories Formulations de dosage pharmaceutique solides
AU2008214199A1 (en) * 2007-02-09 2008-08-14 Poniard Pharmaceuticals, Inc. Encapsulated picoplatin
US8277845B2 (en) * 2007-12-04 2012-10-02 Remedy Pharmaceuticals, Inc. Formulations and methods for lyophilization and lyophilates provided thereby
DE102008004893A1 (de) 2008-01-17 2009-07-23 Add Technologies Ltd. Trägerpellets, Verfahren zu deren Herstellung und deren Verwendung
DE102008037025C5 (de) 2008-08-08 2016-07-07 Jesalis Pharma Gmbh Verfahren zur Herstellung kristalliner Wirkstoff-Mikropartikel bzw. einer Wirkstoffpartikel-Festkörperform
EP2599477A1 (fr) 2011-11-30 2013-06-05 Lunamed AG Formulation à libération prolongée d'acide 4-phénylbutyrique
EP3157516A4 (fr) 2014-06-22 2017-12-13 Dexcel Pharma Technologies Ltd. Compositions pharmaceutiques comprenant du citrate ferrique et procédés de fabrication de celles-ci
MX2020005632A (es) * 2017-12-01 2020-09-03 Cable Components Group Llc Composiciones espumables y metodos para fabricar articulos espumosos.
US11896719B2 (en) 2022-01-24 2024-02-13 Calliditas Therapeutics Ab Pharmaceutical compositions
CN117413659B (zh) * 2023-12-19 2024-04-19 蒙草生态环境(集团)股份有限公司 一种实验室用种子包衣丸化装置

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3565475D1 (en) * 1984-04-07 1988-11-17 Bayer Ag Process and apparatus for the production of granules
US4835188A (en) * 1987-12-08 1989-05-30 American Home Products Corporation Spray dried ibuprofen
IL88961A (en) * 1988-01-29 1992-07-15 Basf Ag Stable mixtures containing oxidation-sensitive compounds
US5145684A (en) * 1991-01-25 1992-09-08 Sterling Drug Inc. Surface modified drug nanoparticles
DE19514187C1 (de) * 1995-04-21 1996-05-15 Degussa Verfahren und Vorrichtung zur Herstellung von Granulaten durch Wirbelschicht-Sprühgranulation
FR2758459B1 (fr) * 1997-01-17 1999-05-07 Pharma Pass Composition pharmaceutique de fenofibrate presentant une biodisponibilite elevee et son procede de preparation
US6013280A (en) * 1997-10-07 2000-01-11 Fuisz Technologies Ltd. Immediate release dosage forms containing microspheres
US7521068B2 (en) * 1998-11-12 2009-04-21 Elan Pharma International Ltd. Dry powder aerosols of nanoparticulate drugs
ATE404178T1 (de) * 1999-02-10 2008-08-15 Pfizer Prod Inc Vorrichtung mit matrixgesteuerter wirkstofffreisetzung
US6264983B1 (en) * 1999-09-16 2001-07-24 Rhodia, Inc. Directly compressible, ultra fine acetaminophen compositions and process for producing same
SE0100822D0 (sv) * 2001-03-09 2001-03-09 Astrazeneca Ab Method II to obtain microparticles
AR033711A1 (es) * 2001-05-09 2004-01-07 Novartis Ag Composiciones farmaceuticas
EP1390047A1 (fr) * 2001-05-11 2004-02-25 Pacific Pharmaceuticals Limited Composition pharmaceutique destinee a masquer le gout de certains medicaments
JP4833464B2 (ja) * 2001-11-28 2011-12-07 大正製薬株式会社 難溶性薬物含有固形製剤の製造方法

Also Published As

Publication number Publication date
EP1631373B1 (fr) 2008-12-24
US20060115539A1 (en) 2006-06-01
DE502004008734D1 (de) 2009-02-05
JP2006527223A (ja) 2006-11-30
WO2004108266A1 (fr) 2004-12-16
PT1631373E (pt) 2009-02-16
ATE418383T1 (de) 2009-01-15
EP1631373A1 (fr) 2006-03-08
ES2318295T3 (es) 2009-05-01
DE10325989A1 (de) 2005-01-05

Similar Documents

Publication Publication Date Title
DK1631373T3 (da) Mikropellets, fremgangsmåde til fremstilling af disse samt deres anvendelse
WO2007092854A3 (fr) DÉRIVÉS DE 2-AMINO-QUINOLÉINE UTILES COMME INHIBITEURS DE LA β-SÉCRÉTASE (BACE)
MXPA05012821A (es) Formulacion farmaceutica que comprende un agente activo insoluble en agua.
WO2005025536A3 (fr) Preparations pharmaceutiques et dispositifs les distribuant
WO2001032830A3 (fr) Compositions de glucuronoxylomannane comme agent nutritif obtenu a partir de champignons basidiomycetes superieurs, techniques et procede de production correspondants
WO2007092846A3 (fr) DÉRIVÉS DE 2-AMINO-3,4-DIHYDRO-QUINOLÉINE UTILES COMME INHIBITEURS DE LA β-SÉCRÉTASE (BACE)
WO2003043631A3 (fr) Procede d'identification d'enzymes de ciblage de tumeurs
WO2006017836A3 (fr) Nouveaux derives de 2-amino-quinazoline utiles en tant qu'inhibiteurs de la $g(b)-secretase (bace)
WO2006102163A3 (fr) Reactifs de transfection pour cellules en suspension non adherentes
WO2006122223A3 (fr) Nouvelles strategies d'administration d'agents actifs utilisant des micelles et des particules
WO2006055511A3 (fr) Formule stable de comprimes
WO2007059008A3 (fr) Indenoisoquinolines n-substituees et leur synthese
WO2006027521A3 (fr) Procede d'obtention d'un principe actif raffermissant et ledit actif
WO2007067828A3 (fr) Mimétiques et polypeptides de glp-2, compositions, méthodes et utilisations
WO2006055532A3 (fr) Procedes de production de formulations de tensioactifs pulmonaires par lyophilisation et formulations et utilisations correspondantes
MXPA05007792A (es) Prodrogas de propofol derivadas de aminoacido, composiciones y usos de las mismas.
WO2006057945A3 (fr) Derives pyridyle 2,3,4,6-substitues utiles comme inhibiteurs de la beta-secretase pour le traitement de la maladie d'alzheimer
WO2007092839A3 (fr) DÉRIVÉS MACROCYCLIQUES UTILES COMME INHIBITEURS DE LA β-SÉCRÉTASE (BACE)
WO2007040574A3 (fr) Nanocomposite biomimetique
WO2005007117A3 (fr) Formulation pharmaceutique et procede de traitement de troubles gastro-intestinaux lies a l'acidite
DE602004024902D1 (de) Verbesserte formulierung zur bereitstellung eines magensaftresitenten beschichtungsmaterials
WO2006110473A3 (fr) Formulations pharmaceutiques a base de phospholipides et leurs procedes de production et d'utilisation.
ATE468398T1 (de) Herstellungsverfahren zur produktion aktiver und löslicher proteine in prokaryonten und polycistronische vektoren dafür
WO2003099202A3 (fr) Inhibiteurs de beta-secretase
WO2006002627A3 (fr) Enzymes de desoxycytidine du poulet et de desoxyadenosine kinase et leur utilisation